{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:44:26Z","timestamp":1793317466841,"version":"4.5.0"},"reference-count":63,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"unspecified","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["#148443"],"award-info":[{"award-number":["#148443"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,2,3]]},"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Statins are considered a promising therapy in traumatic brain injury (TBI) because of their role in mediating inflammatory injury and other endothelial properties. Whether they can improve patient outcomes is unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate the effect of statins in critically ill patients with TBI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Systematic review and meta-analysis of randomised controlled trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Eligibility criteria<\/jats:title>\n                    <jats:p>Trials of adult patients with acute moderate or severe TBI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We searched Medline, Embase, Cochrane Central and Web of Science databases for trials comparing the use of any statin with placebo or other interventions. Our primary outcome was the Glasgow Outcome Scale (GOS or GOS extended); secondary outcomes were mortality, intensive care unit (ICU) and hospital length of stay. We used inverse variance random-effects models to calculate risk ratios (RR) and weighted mean differences. We assessed the risk of bias of trials using the Cochrane risk of bias assessment tool and the presence of statistical heterogeneity using the I\n                      <jats:sup>2<\/jats:sup>\n                      index. Levels of evidence for summary effect measures were evaluated using Grading of Recommendations Assessment, Development and Evaluation methodology.\n                      <jats:sup>1<\/jats:sup>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 2418 retrieved records, 7 trials met our eligibility criteria. Three studied simvastatin, and four studied atorvastatin. The duration of the intervention ranged from 2 to 10 days, and outcomes were assessed between ICU discharge and 6 months. Five trials were considered at high risk of bias. We observed no statistically significant association between statins and the GOS (RR 0.42; 95%\u2009CI, 0.14 to 1.22; two trials; n=84, I\n                      <jats:sup>2<\/jats:sup>\n                      =0%; very low certainty) or mortality (RR 0.59; 95%\u2009CI, 0.25 to 1.44; three trials; n=160, I\n                      <jats:sup>2<\/jats:sup>\n                      =0%; very low certainty). No significant effect was observed for ICU length of stay, while hospital length of stay was evaluated in one trial showing shorter duration.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We found no conclusive evidence supporting the use of statins in critically ill adult patients with TBI at this time. Nevertheless, the trials were limited, and wide confidence intervals resulted in significant uncertainty of the findings. A potential benefit cannot be ruled out, underscoring the need for a larger, well-designed trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD42023421227.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-091971","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:06:03Z","timestamp":1739995563000},"page":"e091971","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Effect of statins on neurological functional outcomes in critically ill adult patients with traumatic brain injury: a systematic review and meta-analysis"],"prefix":"10.1136","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct05551871","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05551871","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8705-0059","authenticated-orcid":false,"given":"Charles","family":"Veillette","sequence":"first","affiliation":[{"name":"CHU de Qu\u00e9bec \u2013 Universit\u00e9 Laval Research Center, Population Health and Optimal Health Practices Research Unit (Trauma \u2013 Emergency \u2013 Critical Care Medicine), Universit\u00e9 Laval, Qu\u00e9bec City, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Umana","sequence":"additional","affiliation":[{"name":"CHU de Qu\u00e9bec \u2013 Universit\u00e9 Laval Research Center, Population Health and Optimal Health Practices Research Unit (Trauma \u2013 Emergency \u2013 Critical Care Medicine), Universit\u00e9 Laval, Qu\u00e9bec City, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Aur\u00e8le","family":"Gagnon","sequence":"additional","affiliation":[{"name":"CHU de Qu\u00e9bec \u2013 Universit\u00e9 Laval Research Center, Population Health and Optimal Health Practices Research Unit (Trauma \u2013 Emergency \u2013 Critical Care Medicine), Universit\u00e9 Laval, Qu\u00e9bec City, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Costerousse","sequence":"additional","affiliation":[{"name":"CHU de Qu\u00e9bec \u2013 Universit\u00e9 Laval Research Center, Population Health and Optimal Health Practices Research Unit (Trauma \u2013 Emergency \u2013 Critical Care Medicine), Universit\u00e9 Laval, Qu\u00e9bec City, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Zarychanski","sequence":"additional","affiliation":[{"name":"Sections of Critical Care and Hematology\/Medical Oncology, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3283-1947","authenticated-orcid":false,"given":"Daniel F","family":"McAuley","sequence":"additional","affiliation":[{"name":"Centre for Experimental Medicine, Queen's University Belfast, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Lawler","sequence":"additional","affiliation":[{"name":"McGill University Health Centre, Montr\u00e9al, Qu\u00e9bec, Canada"},{"name":"University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6530-5513","authenticated-orcid":false,"given":"Francois","family":"Lauzier","sequence":"additional","affiliation":[{"name":"CHU de Qu\u00e9bec \u2013 Universit\u00e9 Laval Research Center, Population Health and Optimal Health Practices Research Unit (Trauma \u2013 Emergency \u2013 Critical Care Medicine), Universit\u00e9 Laval, Qu\u00e9bec City, Qu\u00e9bec, Canada"},{"name":"Department of Medicine, Faculty of Medicine, Universit\u00e9 Laval, Qu\u00e9bec City, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane W","family":"English","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"},{"name":"Division of Critical Care, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne","family":"Moore","sequence":"additional","affiliation":[{"name":"CHU de Qu\u00e9bec \u2013 Universit\u00e9 Laval Research Center, Population Health and Optimal Health Practices Research Unit (Trauma \u2013 Emergency \u2013 Critical Care Medicine), Universit\u00e9 Laval, Qu\u00e9bec City, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chartelin Jean","family":"Isaac","sequence":"additional","affiliation":[{"name":"CHU de Qu\u00e9bec \u2013 Universit\u00e9 Laval Research Center, Population Health and Optimal Health Practices Research Unit (Trauma \u2013 Emergency \u2013 Critical Care Medicine), Universit\u00e9 Laval, Qu\u00e9bec City, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5675-8791","authenticated-orcid":false,"given":"Alexis F","family":"Turgeon","sequence":"additional","affiliation":[{"name":"CHU de Qu\u00e9bec \u2013 Universit\u00e9 Laval Research Center, Population Health and Optimal Health Practices Research Unit (Trauma \u2013 Emergency \u2013 Critical Care Medicine), Universit\u00e9 Laval, Qu\u00e9bec City, Qu\u00e9bec, Canada"},{"name":"Department of Anesthesiology and Critical Care Medicine, Division of Critical Care Medicine, Faculty of Medicine, Universit\u00e9 Laval, Qu\u00e9bec City, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"key":"2025121602532505000_15.2.e091971.1","doi-asserted-by":"crossref","unstructured":"Dewan MC , Rattani A , Gupta S , et al . n.d. Estimating the global incidence of traumatic brain injury. J Neurosurg 130:1080\u201397. doi:10.3171\/2017.10.JNS17352","DOI":"10.3171\/2017.10.JNS17352"},{"key":"2025121602532505000_15.2.e091971.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30415-0"},{"key":"2025121602532505000_15.2.e091971.3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911193","article-title":"Neuro-Inflammation Modulation and Post-Traumatic Brain Injury Lesions: From Bench to Bed-Side","volume":"23","author":"Jacquens","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2025121602532505000_15.2.e091971.4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.308537"},{"key":"2025121602532505000_15.2.e091971.5","doi-asserted-by":"crossref","unstructured":"Schonbeck U , Libby P . n.d. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents? Circulation 109:II18\u201326. doi:10.1161\/01.CIR.0000129505.34151.23","DOI":"10.1161\/01.CIR.0000129505.34151.23"},{"key":"2025121602532505000_15.2.e091971.6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jss.2019.07.081","article-title":"Preinjury Statins Are Associated With Improved Survival in Patients With Traumatic Brain Injury","volume":"245","author":"Lokhandwala","year":"2020","journal-title":"J Surg Res"},{"key":"2025121602532505000_15.2.e091971.7","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1080\/02699052.2020.1802663","article-title":"Statins in survivors of traumatic brain injury: a propensity score-matched analysis","volume":"34","author":"Mansi","year":"2020","journal-title":"Brain Inj"},{"key":"2025121602532505000_15.2.e091971.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.nurt.2009.11.003"},{"key":"2025121602532505000_15.2.e091971.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2007.03.031"},{"key":"2025121602532505000_15.2.e091971.10","doi-asserted-by":"publisher","DOI":"10.1227\/01.NEU.0000346272.76537.DC"},{"key":"2025121602532505000_15.2.e091971.11","first-page":"733","article-title":"The role and mechanism of simvastatin in neuroprotection after diffuse axonal injury","volume":"35","author":"Li","year":"2014","journal-title":"Article Journal of Xi\u2019an Jiaotong University (Medical Sciences)"},{"key":"2025121602532505000_15.2.e091971.12","article-title":"Simvastatin combined with antioxidant attenuates the cerebral vascular endothelial inflammatory response in a rat traumatic brain injury","volume":"2014","author":"Wang","year":"2014","journal-title":"Biomed Res Int"},{"key":"2025121602532505000_15.2.e091971.13","doi-asserted-by":"crossref","first-page":"1021653","DOI":"10.3389\/fphar.2022.1021653","article-title":"Effect of drug therapy on nerve repair of moderate-severe traumatic brain injury: A network meta-analysis","volume":"13","author":"Li","year":"2022","journal-title":"Front Pharmacol"},{"key":"2025121602532505000_15.2.e091971.14","doi-asserted-by":"crossref","first-page":"e266","DOI":"10.1016\/j.wneu.2021.05.083","article-title":"Outcomes of Preinjury Use of Statins in Patients with Traumatic Brain Injury: A Systematic Review and Meta-analysis","volume":"152","author":"Mu","year":"2021","journal-title":"World Neurosurg"},{"key":"2025121602532505000_15.2.e091971.15","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-016-0355-2"},{"key":"2025121602532505000_15.2.e091971.16","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1089\/neu.2018.5738","article-title":"Efficacy and Harms of Pharmacological Interventions for Neurobehavioral Symptoms in Post-Traumatic Amnesia after Traumatic Brain Injury: A Systematic Review","volume":"35","author":"Hicks","year":"2018","journal-title":"J Neurotrauma"},{"key":"2025121602532505000_15.2.e091971.17","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1089\/neu.2018.6244","article-title":"Prophylaxis Pharmacotherapy to Prevent the Onset of Post-Traumatic Brain Injury Depression: A Systematic Review","volume":"36","author":"Clay","year":"2019","journal-title":"J Neurotrauma"},{"key":"2025121602532505000_15.2.e091971.18","article-title":"Statins\u2019 Effect on Cognitive Outcome After Traumatic Brain Injury: A Systematic Review","volume":"13","author":"Sultan","year":"2021","journal-title":"Cureus"},{"key":"2025121602532505000_15.2.e091971.19","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/17474930211004277","article-title":"Stroke risk following traumatic brain injury: Systematic review and meta-analysis","volume":"16","author":"Turner","year":"2021","journal-title":"Int J Stroke"},{"key":"2025121602532505000_15.2.e091971.20","first-page":"813","article-title":"Effects of statins on mortality and neurologic outcomes in patients with traumatic brain injury: a meta-analysis","volume":"102","author":"Wu","year":"2022","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"2025121602532505000_15.2.e091971.21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.wneu.2022.07.079","article-title":"The Effect of Statins on the Recurrence of Chronic Subdural Hematomas: A Systematic Review and Meta-Analysis","volume":"166","author":"Monteiro","year":"2022","journal-title":"World Neurosurg"},{"key":"2025121602532505000_15.2.e091971.22","unstructured":"Higgins JPT , Thomas J , Chandler J , et al . Cochrane Handbook for Systematic Reviews of Interventions. Cochrane, 2023. Available: www.training.cochrane.org\/handbook"},{"key":"2025121602532505000_15.2.e091971.23","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2025121602532505000_15.2.e091971.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2016.01.021"},{"key":"2025121602532505000_15.2.e091971.25","first-page":"130","article-title":"How to identify randomized controlled trials in MEDLINE: ten years on","volume":"94","author":"Glanville","year":"2006","journal-title":"J Med Libr Assoc"},{"key":"2025121602532505000_15.2.e091971.26","first-page":"41","article-title":"Developing optimal search strategies for detecting clinically sound treatment studies in EMBASE","volume":"94","author":"Wong","year":"2006","journal-title":"J Med Libr Assoc"},{"key":"2025121602532505000_15.2.e091971.27","unstructured":"RCT Filters used by Cochrane ENT . Cochrane ENT group. Available: https:\/\/ent.cochrane.org\/sites\/ent.cochrane.org\/files\/public\/uploads\/rct_filters.pdf [Accessed 20 Mar 2023]."},{"key":"2025121602532505000_15.2.e091971.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2010.06.033"},{"key":"2025121602532505000_15.2.e091971.29","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(75)92830-5"},{"key":"2025121602532505000_15.2.e091971.30","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.44.4.285"},{"key":"2025121602532505000_15.2.e091971.31","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2025121602532505000_15.2.e091971.32","doi-asserted-by":"publisher","DOI":"10.1177\/0962280216669183"},{"key":"2025121602532505000_15.2.e091971.33","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"2025121602532505000_15.2.e091971.34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"2025121602532505000_15.2.e091971.35","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000625"},{"key":"2025121602532505000_15.2.e091971.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.04.026"},{"key":"2025121602532505000_15.2.e091971.37","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/11101849.2023.2246232","article-title":"The anti-inflammatory effects of atorvastatin upon the outcome of traumatic brain injury patients: A randomized-controlled double-blind clinical trial","volume":"39","author":"Zarief Kamel","year":"2023","journal-title":"Egypt J Anaesth"},{"key":"2025121602532505000_15.2.e091971.38","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4103\/roaic.roaic_46_22","article-title":"Efficacy of simvastatin in treating patients with traumatic brain injury","volume":"10","author":"Hassanin","year":"2023","journal-title":"Research and Opinion in Anesthesia & Intensive Care"},{"key":"2025121602532505000_15.2.e091971.39","unstructured":"Nct . Effects of usage of simvastatin in mild to moderate traumatic brain injury (tbi) patients. 2022. Available: https:\/\/clinicaltrialsgov\/show\/NCT05551871"},{"key":"2025121602532505000_15.2.e091971.40","unstructured":"Irct201109197597N . Effect of simvostatin in traumatic brain injury. trial registry record; clinical trial protocol. 2011. Available: https:\/\/trialsearchwhoint\/Trial2aspx?TrialID=IRCT201109197597N1"},{"key":"2025121602532505000_15.2.e091971.41","unstructured":"Irct20230627058603N . Rosuvastatin in patients with moderate brain trauma. trial registry record. 2024. Available: https:\/\/trialsearchwhoint\/Trial2aspx?TrialID=IRCT20230627058603N2"},{"key":"2025121602532505000_15.2.e091971.42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3906\/sag-1404-125","article-title":"Simvastatin\u2019s effects on survival and outcome in traumatic braininjury patients: a comparative study","volume":"46","author":"Naghibi","year":"2016","journal-title":"Turk J Med Sci"},{"key":"2025121602532505000_15.2.e091971.43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jocn.2017.06.010","article-title":"Effects of atorvastatin on brain contusion volume and functional outcome of patients with moderate and severe traumatic brain injury; a randomized double-blind placebo-controlled clinical trial","volume":"44","author":"Farzanegan","year":"2017","journal-title":"J Clin Neurosci"},{"key":"2025121602532505000_15.2.e091971.44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5812\/ans.106867","article-title":"The Effect of Low-Dose Atorvastatin on Inflammatory Factors in Patients with Traumatic Brain Injury: A Randomized Clinical Trial","volume":"7","author":"Soltani","year":"2020","journal-title":"Arch Neurosci"},{"key":"2025121602532505000_15.2.e091971.45","first-page":"807","article-title":"The Effect of Oral Simvastatin on the Clinical Outcome of Patients with Severe Traumatic Brain Injury: A Randomized Clinical Trial","volume":"31","author":"Shafiee","year":"2021","journal-title":"Ethiop J Health Sci"},{"key":"2025121602532505000_15.2.e091971.46","doi-asserted-by":"crossref","DOI":"10.5812\/aapm.117140","article-title":"Evaluation of the Effect of Atorvastatin Administration on the Outcomes of Patients with Traumatic Brain Injury: A Double-blinded Randomized Clinical Trial","volume":"11","author":"Soltani","year":"2021","journal-title":"Anesth Pain Med"},{"key":"2025121602532505000_15.2.e091971.47","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10143-019-01218-w","article-title":"Evaluation of the efficacy of atorvastatin in the treatment for chronic subdural hematoma: a meta-analysis","volume":"44","author":"He","year":"2021","journal-title":"Neurosurg Rev"},{"key":"2025121602532505000_15.2.e091971.48","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70084-5"},{"key":"2025121602532505000_15.2.e091971.49","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1016\/j.wneu.2019.07.016","article-title":"Efficacy of Statins in Cerebral Vasospasm, Mortality, and Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"131","author":"Shen","year":"2019","journal-title":"World Neurosurg"},{"key":"2025121602532505000_15.2.e091971.50","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-019-1298-5","article-title":"Comparison of statins for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis","volume":"17","author":"Tramacere","year":"2019","journal-title":"BMC Med"},{"key":"2025121602532505000_15.2.e091971.51","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/ene.14196","article-title":"Statin treatment and accrual of covert cerebral ischaemia on neuroimaging: a systematic review and meta-analysis of randomized trials","volume":"27","author":"Katsanos","year":"2020","journal-title":"Eur J Neurol"},{"key":"2025121602532505000_15.2.e091971.52","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-015-2512-7"},{"key":"2025121602532505000_15.2.e091971.53","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-005-0651-y"},{"key":"2025121602532505000_15.2.e091971.54","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.44.s.1.7.x"},{"key":"2025121602532505000_15.2.e091971.55","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-34560-7","article-title":"Traumatic brain injury related deaths in residents and non-residents of 30 European countries: a cross-sectional study","volume":"13","author":"Sivco","year":"2023","journal-title":"Sci Rep"},{"key":"2025121602532505000_15.2.e091971.56","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6846a2"},{"key":"2025121602532505000_15.2.e091971.57","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.ss6609a1"},{"key":"2025121602532505000_15.2.e091971.58","first-page":"1","article-title":"Surveillance for traumatic brain injury-related deaths--United States, 1997-2007","volume":"60","author":"Coronado","year":"2011","journal-title":"MMWR Surveill Summ"},{"key":"2025121602532505000_15.2.e091971.59","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s10787-022-01017-8","article-title":"Pathogenesis and management of traumatic brain injury (TBI): role of neuroinflammation and anti-inflammatory drugs","volume":"30","author":"Kalra","year":"2022","journal-title":"Inflammopharmacology"},{"key":"2025121602532505000_15.2.e091971.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2007.10.005"},{"key":"2025121602532505000_15.2.e091971.61","doi-asserted-by":"publisher","DOI":"10.1097\/MCC.0b013e3280895d5c"},{"key":"2025121602532505000_15.2.e091971.62","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.100894","article-title":"Individualized Dose-Response to Statins Associated with Cardiovascular Disease Outcomes","volume":"3","author":"Aggarwal","year":"2024","journal-title":"JACC Adv"},{"key":"2025121602532505000_15.2.e091971.63","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94803-3","article-title":"Association between statin use and Alzheimer\u2019s disease with dose response relationship","volume":"11","author":"Jeong","year":"2021","journal-title":"Sci Rep"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-091971","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T10:53:39Z","timestamp":1765882419000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-091971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":63,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,19]]},"published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1136\/bmjopen-2024-091971"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-091971","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}